Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, 15782, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain; Special Care Dentistry Centre (CAPE), School of Dentistry of University of São Paulo (FOUSP), São Paulo, Brazil; Department of Stomatology, School of Dentistry of University of São Paulo (FOUSP), São Paulo, Brazil
Auto-generated profile, based on publicly available information
Janaina Braga Medina
Oral Medicine, Oral Surgery and Implantology Unit (MedOralRes), Faculty of Medicine and Dentistry, 15782, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain; Special Care Dentistry Centre (CAPE), School of Dentistry of University of São Paulo (FOUSP), São Paulo, Brazil; Department of Stomatology, School of Dentistry of University of São Paulo (FOUSP), São Paulo, Brazil
Background: Torque teno virus (TTV) is not known to cause disease in humans; however, chronic inflammatory conditions and immunosuppression states can favour TTV replication. This study aimed to verify the effectiveness of TTV as an immune biomarker.Methods: The protocol of this review was registered in PROSPERO (CRD42022331049) and performed according to the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines.Results: Thirty‐three articles were selected and different groups of patients were assessed. In the solid organ and hematopoietic stem cell transplant groups, most studies reported that TTV viral load (VL) was highly detectable after transplantation and compared to controls, but the association with immune parameters showed conflicting results. In melanoma patients, no statistical difference in TTV VL was identified between susceptible and treatment‐resistant patients. In lung cancer patients, viral load increases significantly with disease progression but decreases after chemotherapy. HIV‐positive patients showed a higher VL than controls, but an inverse correlation with CD4+ was observed in half of the studies. Although 57.14% of all studies presented a low risk of bias, significant differences were observed between studies, particularly in the choice of the analyzed outcome, the parameter used to evaluate the patient's immune status, the presence of a control group, and the sample collection time points.Conclusions: Although TTV seems to have the potential to be a promising biomarker of immunosuppression, further high‐quality prospective clinical studies are still needed.
1 February 2022 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Objective: This work measures the intra‐operative bleeding in end‐stage renal disease patients and assesses whether laboratory coagulation tests and nitrogenous compounds are related to a higher bleeding risk.Methods: Laboratory tests were performed on the day of surgery and some patients with thrombocytopenia and values above the normal levels of international normalised ratio (INR), thrombin time (TT) and activated partial thromboplastin time (aPTT) were identified.Results: Haemostatic time ranged from 2 to 35 min (mean of 8.51 min) after suture. Bleeding volume ranged from 0.02 to 67.06 mL (mean of 4.38 mL) and the bleeding volume per minute ranged from 0.05 to 2.10 mL/min (median of 0.6 mL/min). Only seven patients (16.27%) had abnormal bleeding (more than 0.6 mL/min). Spearman's coefficient showed weak correlations between bleeding volume (mL/min) and serum urea (r = 0.226), TT (r = 0.227), plasma urea (r = 0.148) and creatinine (r = 146), as well as very weak correlations with all other variables (r < 0.140) such as age, haemodialysis time, glycaemia, glycated haemoglobin, platelets, INR, aPTT and fibrinogen.Conclusion: It was not possible to associate any laboratory test or nitrogenous compounds present in the blood and saliva with an increased bleeding.
11 December 2025 in Journal of Stomatology Oral and Maxillofacial Surgery
Malignant neoplasms of any anatomical site, along with their treatments, can significantly affect the oral health of paediatric and adolescent populations, potentially influencing their oral health–related quality of life (OHRQoL). This systematic review sought to evaluate how cancer, regardless of tumour location, impacts the OHRQoL of children and adolescents. Electronic searches were conducted in PubMed, Scopus, EMBASE, Web of Science and LILACS, as well as grey literature, up to October 2023. Clinical studies reporting on OHRQoL in patients aged 0–19 years with cancer were included. Two reviewers independently performed study selection, data extraction and risk of bias assessment using the Joanna Briggs Institute tools. Certainty of evidence was evaluated using the GRADE approach. Of 27,684 records, four studies (three cross‐sectional and one randomised clinical trial) met the inclusion criteria, encompassing 253 paediatric patients. OHRQoL was assessed using OHIP‐14 and ECOHIS instruments. Most studies reported a weak impact of oral health on quality of life. However, methodological limitations and very low certainty of evidence were identified. Although a weak impact of oral health on quality of life was observed among children and adolescents with malignant neoplasms, the limited number and quality of available studies prevent firm conclusions. High‐quality research with robust methodology is needed to better understand this relationship and draw robust conclusions and guide clinical decision‐making.